U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888556) titled 'Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study' on Oct. 15.
Brief Summary: To explore the duration of continued treatment for patients with advanced breast cancer who achieve complete response assessed by PET-CT after receiving systemic anti-tumor therapy.
Study Start Date: Oct., 2026
Study Type: OBSERVATIONAL
Condition:
Advanced Breast Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Henan Cancer Hospital
Information provided by (Responsible Party): Min Yan, MD, Henan Cancer Hospital
Published by HT Digital Content Services with permission from Health Daily Di...